Defects in embryonic patterning resulting in craniofacial abnormalities are common birth 14 defects affecting up to 1 in 500 live births worldwide, and are mostly non-syndromic. 15 The regulatory programs that build and shape the craniofacial complex are thought to 16 be controlled by information encoded in the genome between genes and within intronic 17 sequences. Early stages of human craniofacial development have not been interrogated 18 with modern functional genomics techniques, preventing systematic analysis of genetic 19 associations with craniofacial-specific regulatory sequences. Here we describe a 20 comprehensive resource of craniofacial epigenomic annotations and systematic, 21 integrative analysis with a variety of human tissues and cell types. We identified 22 thousands of novel craniofacial enhancers and provide easily accessible genome 23 annotations for craniofacial researchers and clinicians. We demonstrate the utility of our 24 data to find likely causal variants for craniofacial abnormalities and identify a large 25 enhancer cluster that interacts with HOXA genes during craniofacial development.
Introduction 27
Formation of the craniofacial complex is an intricate process of precisely timed events 28 that occurs relatively early in vertebrate embryonic development. For example, in 29 human embryonic development the majority of the events that lead to the formation of 30 the human face and skull occur during the first ten weeks of gestation 1 . Defects in the 31 orchestration of these events result in several different congenital abnormalities 32 including failure of features to fuse (orofacial clefting) and premature fusion of structures 33 (craniosynostosis). Worldwide, orofacial clefting is one of the most common birth 34 defects, affecting ~1 in 700 live births 2 . The majority of those affected with these types 35 of clefting do not have defects in other tissues or organ systems and thus are referred to 36 as "non-syndromic" 3 . While these birth defects are largely repairable through surgical 37 means, the financial, sociological, and psychological effects have a much broader 38 impact and represent a significant public health burden 4-7 . Screening, prevention, and 39 non-surgical therapeutic options are thus highly desirable. The high heritability of such 40 disorders suggests a major genetic component 8, 9 ; however, causative genetic changes 41 have only been identified in a fraction of those affected 10 . Candidate gene approaches 42 have identified mutations in seven different genes that explain less than ten percent of 43 non-syndromic orofacial clefting cases 11 . In the past decade, several genome wide 44 association studies, copy number variant analyses, and whole exome sequencing 45 studies have sought to identify additional genetic sources of non-syndromic orofacial 46 clefting [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] . These studies identified common and rare variants associated with 47 orofacial clefting, but most are located in non-coding portions of the genome. Our 48 genomes are littered with gene regulatory sequences, located primarily in intronic and 49 intergenic sequences, that are active in a small number of tissues and/or developmental 50 stages in humans 22 . While the regulatory potential of the human genome is still not 51 completely understood, defects in regulatory sequences can cause non-syndromic 52 developmental defects in humans and mice [23] [24] [25] [26] . These findings, coupled with the non-53 syndromic nature of most orofacial clefting cases, suggest defective gene regulatory 54 sequences may underlie much of the incidence of orofacial clefting. However, mapping 55 of chromatin states and identification of craniofacial-specific regulatory sequences has 56 been ignored by large functional genomics efforts such as ENCODE and Roadmap 57 Epigenome 22 . The lack of craniofacial-specific gene regulatory information has impeded 58 the identification of regulatory circuitry important for human craniofacial development 59 and has prevented accurate interpretation of clinical genetic findings in patients with 60 craniofacial disorders. Lastly, without sufficient biological context, prioritization and 61 developing of hypotheses to test genetic associations with craniofacial abnormalities are 62 hindered [27] [28] [29] [30] . Here we present a comprehensive resource of functional genomics data 63 and predicted chromatin states for important stages of early human craniofacial 64 development. We have profiled multiple biochemical marks of chromatin activity in 65 developing human craniofacial tissue samples encompassing 4.5 to 8 post conception 66 weeks. We have comprehensively compared these data with publicly available genomic 67 and genetic data from 127 epigenomes which include a wide variety of adult and fetal 68 tissues. We provide annotations consistent with large consortia efforts 22 in formats 69 easily loadable into modern genome browsers to enable exploration by other 70 researchers without large computational effort. We demonstrate how to mine this data 71 for biological features relevant to craniofacial development and how to experimentally 72 validate target gene interactions. In total, our analyses have identified thousands of 73 previously unknown craniofacial enhancer sequences. These analyses will facilitate 74 interpretation of genetic variation in the context of congenital craniofacial defects, and 75 will enable future experimental testing of enhancer-target gene interactions in 76 developing craniofacial tissues.
77

Results
78
Profiling of Histone Modifications in Developing Human Embryonic Craniofacial
79
Tissue. 80 Chromatin immunoprecipitation of post-translational histone modifications coupled with 81 next generation sequencing (ChIP-Seq) is a powerful method to identify active 82 regulatory sequences in a global fashion from a wide variety of biological contexts 22 . 83 Many of the regulatory elements identified by this method are specific to the biological 84 context queried 31,32 (i.e. tissue type or developmental stage) and are enriched for 85 genetic associations with disease in a relevant tissue (i.e. immune-related disorder 86 associations in immune cell-specific enhancers) 33, 34 . To identify regulatory sequences   87   important for human craniofacial development, we utilized ChIP-Seq of six post-88   translational histone modifications across multiple stages and multiple biological   89 replicates of early human craniofacial development. We focused our efforts on histone 90 modifications both profiled by large consortia and strongly associated with multiple 91 states of chromatin activity. We performed parallel ChIP-Seq experiments on 92 craniofacial tissues obtained from 17 individual human embryos spanning the critical 93 window for the formation of the human orofacial apparatus (Fig. 1a) . Specifically, we 94 profiled marks ranging from those associated with repression (H3K27me3), promoter 95 activation (H3K4me3), active transcription (H3K36me3), and various states of enhancer 96 activation (H3K4me1, H3K4me2, and H3K27ac) ( Fig. 1b) 35 . We profiled at least three 97 biological replicates for four distinct Carnegie stages (CS) (CS13, CS14, CS15, and 98 CS17) encompassing 4.5 post conception weeks (pcw) to 6 pcw. We also profiled single 99 biological samples from CS20 (8 pcw) and 10 pcw embryos ( Fig. 1c) . We obtained over 100 5.3 billion ChIP-Seq reads across a total of 106 datasets, with mean total reads and 101 uniquely aligned reads per sample of 50.3 and 37.3 million respectively 102 ( Supplementary Table 1 ). Overall the samples correlated well by mark and stage of 103 development ( Fig. 2a and Supplementary Fig. 1 ). We uniformly processed these data 104 to identify reproducibly enriched regions for each mark within each stage. The genomic 105 features identified by each set of enriched regions closely mirror what has previously 106 been reported for each of these post-translational marks ( Fig. 2b and 32, 35 . For example, we observed very strong enrichment of H3K4me3 at 108 promoters of genes and identified a large number of intronic or intergenic regions 109 enriched for H3K27ac. When we examined all the samples for a given Carnegie stage, 110 we identified thousands of enriched regions, at each stage for each mark, that were 111 found in at least two biological replicates ( Fig. 2c) .Combined, these results indicated 112 our ChIP-Seq data from human embryonic tissues were of high quality, reflected the 113 previously described nature of these marks, and was likely to identify tissue-specific 114 regulatory sequences. 116   Defining enriched regions for a single histone modification such as H3K27ac has   117   been utilized to identify active regulatory sequences from a variety of tissues, biological   118 contexts, and different species [36] [37] [38] [39] [40] such available data to identify regulatory information likely to be critical for craniofacial 126 development, we processed our data in a uniform fashion to match those generated by 127 Roadmap Epigenome (Methods) 22 . Using p-value based signals 47,48 for each of the six 128 epigenomic marks we assayed, along with the same type of signals for 12 epigenomic 129 marks for 127 tissues and cell types generated by Roadmap Epigenome, we imputed 130 our data to create a uniform, directly comparable dataset 49 (Fig. 1c) . The imputed 131 samples' signals correlated well with their primary signals and clustered generally by 132 mark and biological function ( Fig. 3a and Supplementary Fig. 3 ). Using the imputed 133 craniofacial data, we then segmented the genome for each embryonic sample based on 134 previously generated models of 15, 18, and 25 states of chromatin activity 22 . We 135 identified similar numbers and proportions of segments in each state in our tissues ( Fig.   136 3b and Supplementary Fig. 4 ).The 25-state model results showed the most similar 137 trends across these measures and utilized all of the primary data generated in our study 138 when compared to those previously generated by Roadmap Epigenome (Fig. 3c,d and 139 Supplementary Fig. 4) ; therefore we focused our downstream analyses on these 140 segmentations. Using the 25-state segmentations, we reproducibly identified 75928 141 segments in at least one of six enhancer categories defined by Roadmap Epigenome 142 (EnhA1, EnhA2, EnhAF, EnhW1, EnhW2, and EnhAc). To determine if these 143 segmentations are enriched for craniofacial enhancers, we first turned to a large catalog 144 of experimentally validated developmental enhancers tested in mouse embryos and 145 available in the Vista Enhancer Browser 50 . We identified over 80% of all craniofacial-146 positive enhancers in this database. Moreover, our enhancer annotations were 147 significantly enriched for craniofacial enhancers versus those that lacked craniofacial 148 activity (p = 3.28 x 10 -14 ) (Fig. 4a,b and Supplementary Fig. 5 ). While these results are 149 encouraging -namely, that our data identified craniofacial enhancers -they did not 150 reveal any specificity for craniofacial tissues in our chromatin state annotations. To were ever annotated as such in the 127 samples obtained from Roadmap Epigenome. 161 We identified 6651 enhancer segments (8.7% of total craniofacial enhancer segments) 162 in our craniofacial epigenomic atlas that were never annotated as any type of enhancer 163 state in all of Roadmap Epigenome ( Supplementary Table 2 ). To determine if these 164 sites are relevant for craniofacial development or represent spurious segmentations in 165 our data we analyzed sequence content of these regions and functional enrichments of 166 genes potentially regulated by these regions. When we assessed the novel craniofacial-167 specific enhancers for enrichment of transcription factor binding sites, we identified 168 motifs matching those of TWIST2, LMX1B, SIX1, NKX6.1, multiple members of the LHX 169 and HOX families, and TCF12, all of which have been implicated in craniofacial and 170 skeletal development 51-57 ( Fig. 4d and Supplementary Table 3 ). Utilizing the Genomic 171 Regions Enrichment of Annotations Tool (GREAT) 58 , we found significant enrichment of 172 craniofacial-specific enhancers assigned to genes associated with craniofacial 173 abnormalities such as cleft palate in both humans and mice ( Fig. 4e and 174 Supplementary Fig. 7) . Interestingly, we also identified more general categories of 175 enrichment amongst the putative gene targets including general transcriptional 176 activators ( Supplementary Table 4 ). When we interrogated this list of transcription 177 factors, we found significant enrichment for expression in both craniofacial and 178 appendicular skeleton ( Fig. 4f) . These results suggest that many of the novel 179 craniofacial enhancers we identified are likely to play a direct role in patterning of the 180 bones of the face, jaws, and portions of the skull. However, it is unclear whether they 181 are directly involved in human craniofacial abnormalities. 182 To begin to explore this uncertainty, we turned to genome wide association data 183 obtained from the GWAS catalog related to orofacial clefting and craniofacial 184 morphology 17,21,59-63 . We overlaid associations from these studies with each of the 185 segmentation maps from our data, as well as data from Roadmap Epigenome, and 186 assessed enrichment. We observed significant enrichment of orofacial clefting tag SNPs 187 in most of our craniofacial samples and relatively few Roadmap Epigenomes 188 ( Supplementary Fig. 8a ). These analyses identified several enhancer segments that 189 directly contain strong genetic associations. For instance, we identified a discrete 190 enhancer state in the noncoding region between IRF6 and DIEXF that contains a tag 191 SNP previously associated with non-syndromic cleft lip and palate 64 (Supplementary 192 Fig. 8b ). This particular region can directly influence IRF6 expression and is potentially 193 a causative allele for orofacial clefting 65 .We also identified 13 other regions that are 194 identified in craniofacial tissue and directly contain such tag SNPs, including an intronic 195 sequence of the TXNDC16 gene 59 ( Supplementary Fig. 8c and Supplementary Table   196 5). These findings suggest that our chromatin state maps will be extremely useful in 197 identifying and prioritizing causative variation in patients affected by craniofacial 198 abnormalities.
115
Generation of Human Craniofacial Chromatin State Segmentations
199
Machine learning approaches to mining of activated craniofacial enhancer data. 200 To more comprehensively explore our data for regions likely to be important for 201 craniofacial development and human disease, we turned to the unsupervised machine 202 learning method known as self-organizing maps. This approach is a powerful means to 203 identify relationships within large genomic datasets, but also allows fine-grained 204 analysis relevant to specific biological questions 66 . We first extracted H3K27ac signals 205 from all of our craniofacial samples and all Roadmap Epigenome samples across all 206 enhancer segmentations, resulting in signal measurements for 425000 enhancer 207 segments in 146 epigenomes.The resulting matrix was used to train a self-organizing 208 toroid map with a map size of 2500 units; we selected the best scoring map from 50 209 map building trials. We then clustered each of the units of the map into metaclusters 210 and found 199 that identify enhancer segments that have similar signal properties and 211 are likely to be biologically related ( Fig. 5a) . For each enhancer segment, we assigned 212 potential target genes and overlaid the gene assignments to each unit. Based on these 213 gene assignments, we then determined the gene and human phenotype ontology 214 enrichments of each unit. This resource is available for interrogation via a standard web 215 browser, allowing for retrieval of regions, genes, and functional associations for each 216 unit and metacluster. Inspection of this map identified several metaclusters that showed 217 distinct H3K27ac activation in craniofacial tissues. These clusters were enriched for a 218 number of ontologies related to craniofacial biology and abnormalities. For example, we 219 identified a metacluster that showed significantly increased H3K27ac signal in 220 craniofacial samples relative to other tissue types and that is enriched for potential 221 target genes associated with various craniofacial abnormalities ( Fig. 5b) . We obtained 222 similar types of functional enrichments when performing k-means clustering directly on 223 the matrix of H3K27ac signals using the same number of clusters utilized for the self-224 organizing map ( Supplementary Fig. 9a and Supplementary Table 6 ). When we 225 assessed the sequence content of clusters most specific for craniofacial activity, we 226 identified enrichment of motifs for the ALX, DLX, HOX, and MSX families of transcription 227 factors ( Supplementary Fig. 9b ).
228
Identification of novel craniofacial locus control region and potential regulatory
229 targets 230 Thus far, our analyses have focused on the annotation and activation state of individual 231 genome segments in bulk. However, these enhancers likely do not operate in isolation 232 and clusters of enhancers activated in concert have been shown to be powerful 233 regulators of important genes for a given tissue or cell type 67 . To identify such enhancer 234 clusters, we applied a sliding window approach to detect enrichment of craniofacial 235 enhancer states relative to both randomly chosen sequences as well as those identified 236 by Roadmap Epigenome. We identified 582 regions across the genome that 237 demonstrate high levels of craniofacial enhancer activity ( Supplementary Table 7 ). 238 These windows had an average size of ~400kb but ranged up to 2 Mb in length. In 239 many cell types these clusters of enhancers, sometimes referred to as super 240 enhancers, are embedded in the genome both surrounding and within the introns of 241 their likely tissue-specific target 68 . Indeed, most of the windows we identified contained 242 multiple genes and were enriched for developmental genes, including multiple Frizzled, 243 WNT, ALX, DLX, and TBX family members ( Supplementary Table 8 ). Interestingly, we 244 identified 37 large windows that were located entirely in intergenic space and did not (Supplementary Fig. 10) . We tested an element 261 annotated as a bivalent chromatin state, which is highly conserved across mammals, 262 near this chromatin boundary for enhancer activity 71 . It displayed strong craniofacial and 263 limb enhancer activity in the E11.5 mouse embryo (Fig. 6a) . Inspection of chromatin 264 data from Mouse ENCODE 72 indicate similar patterns of activation in the orthologous 265 window, suggesting functional conservation of chromatin state in this large region 266 (Supplementary Fig. 11 ). Having demonstrated that this region is enriched for 267 craniofacial enhancers and active chromatin states, we sought to determine the gene(s) 268 this region interacts with and potentially regulates. This region is located between the 269 NPVF and NFE2L3 genes, neither of which appears to be active based on observed 270 chromatin states in developing human craniofacial tissue. The next closest target is 271 CBX3, which is strongly expressed in most cell types and has similar chromatin states 272 in both our tissues and in Roadmap Epigenome. Comparisons of the mouse and human 273 genomes revealed this window is part of a large syntenic block between the two species 274 which stretches nearly 10 Mb in length with the HOXA gene cluster at its center 275 ( Supplementary Fig. 12) . The enrichment for craniofacial enhancer annotations, identified region as well as significant interactions with the HOXA gene cluster (Fig. 6b) . 297 To confirm these interactions, we performed additional 4C-seq experiments utilizing 298 viewpoints located directly within the HOXA cluster and the promoter of the SKAP2 299 gene. We observed strong interactions between both of these viewpoints and the TAD 300 boundary of the original window. Interestingly, HOXA made contacts with the outer 301 limits of this window but not within the window. These findings illustrate that the region 302 we identified in human craniofacial tissue makes strong contacts over nearly 1.5 Mb 303 with genes of the HOXA cluster in developing mouse craniofacial tissue and indicate it 304 could be a conserved global control region important for craniofacial development. (Supplementary Fig. 13) . These findings illuminate that 330 our current understanding of the regulatory information our genomes encode is 331 incomplete and reinforces the need for more and higher resolution tissue-specific 332 chromatin state annotations. 333 To illustrate the utilization of this resource we analyzed these data in many Acknowledgements 372 We would like to thank the donors to HDBR, as without them this resource would not be 373 possible. We would also like to thank Camden Jansen and Ali Mortazavi for assistance ChIP-Seq was performed as described in Cotney and Noonan, 2015 79 . Briefly, each tissue 402 sample was rapidly thawed in 1 mL of ice cold phosphate buffered saline (PBS) and briefly 403 homogenized with a disposable plastic pestle in a 1.5 mL microcentrifuge tube. Samples were 404 then fixed by the addition of formaldehyde to a final concentration of 1% and incubated at room 405 temperature on a rotisserie for 15 minutes. Samples were then quenched with 150 mM glycine 406 at 10 minutes at room temperature. Tissue was collected by centrifugation (5 min, 2500g, 4 ) 407 and washed with 1 mL of fresh PBS. Fixed tissue pellets were then rapidly frozen in a dry 408 ice/alcohol bath and stored at -80 until batch processing for chromatin immunoprecipitation 409 (ChIP). 410
Antibody Specifications
411
Antibodies used in this study: anti-H3K27ac (ab4729, Abcam), anti-H3K4me1 (ab8895, Abcam), 412 anti-H3K4me2 (ab7777, Abcam), anti-H3K4me3 (ab8580, Abcam), anti-H3K27me3 (07-449, 413 EMD Millipore), anti-H3K36me3 (ab9050, Abcam). 414
ChIP-Seq
415
Fixed tissue pellets were processed for ChIP as previously described 79 . Briefly, samples were 416 thawed in 1 mL of 1x Cell Lysis buffer and incubated on ice for 20 minutes. Cells were lysed 417 with dounce homogenization and nuclei were collected by centrifugation (5 min, 2500g, 4 ).
Nuclei were resuspended in 300 µL of 1x Nuclear Lysis buffer + 0.3% SDS + 2 mM sodium 419 butyrate and incubated on ice for 20 minutes. Chromatin was sheared with a Qsonica Q800R1 420 sonicator system operating at amplitude 20 and 2 for 30 minutes (10 seconds duty, 10 421 seconds rest). Samples were cleared by centrifugation (5 min, 20,000g, 4 ) and soluble 422 chromatin was transferred equally into six separate tubes with 10% reserved as an input control. EnhAF, EnhW1, EnhW2, and EnhAc) using deepTools2 86 . All plots were made using tabular 482 data generated by deepTools2 in R (v3.3.3) 87 . 483 
Functional Enrichments in Craniofacial Epigenomes
Self-Organizing Maps of Enhancer Activation
502
The self-organizing map of H3K27ac signal at all enhancer segments was generated as 503 previously described 66 . Briefly, a union of all enhancer segmentations from craniofacial tissues 504 and all samples in Roadmap Epigenome was generated and merged to form a consistent 505 annotation of enhancers across the entire genome resulting in 425380 individual enhancer 506 segments. H3K27ac signals from imputed p-value signal tracks for each of the 146 epigenomes 507 were extracted for each of the 425380 enhancer segments. This matrix was then used to train a 508 self-organizing map with 50 rows and 50 columns (2500 units) to allow for the possibility of 509 small numbers of highly tissue-specific enhancers (<200) to be clustered together. We 510 performed 50 training trials and retained the best scoring map. For this final self-organizing map 511 we then annotated each unit with Ensembl (v75) genes based on association rules defined by 512 GREAT 58 . Based on these unit/gene assignments we then determined enrichment of gene 513 ontologies (http://geneontology.org/ontology/go.obo) and human phenotype ontologies from the 514 Monarch Initiative 90 (http://purl.obolibrary.org/obo/hp.obo) as previously described 91 . Clusters of 515 units, or metaclusters, were then determined with four separate trials testing for the presence of 516 up to 250 metaclusters as previously described 66 . The algorithm converged on 199 clusters as 517 optimal for the self-organizing map generated above. Metaclusters were then assessed for 518 functional enrichments as was done for individual units above. Metaclusters identified as 519 specific for craniofacial and brain tissues were visualized using a JavaScript web-based viewer 520 of the self-organizing map available here: 521 https://cotneylab.cam.uchc.edu/~jcotney/CRANIOFACIAL_HUB/Craniofacial_H3K27ac_SOM/ 522
K-means clustering of Enhancer Activation
523
K-means clustering of the same H3K27ac signal matrix utilized for the self-organizing map was 524 performed using Cluster (v3.0) 92 . Rows were centered on the mean value of the row and 525 normalized, the number of metaclusters identified in the self-organizing map analysis above was 526 used as the k parameter, and 100 runs were performed. The clustering result was then 527 visualized and craniofacial-specific clusters were extracted using Java TreeView 93 . Sequences 528 underlying the enhancers in the craniofacial-specific clusters were extracted as above for novel 529 craniofacial enhancers. We performed motif enrichment within these sequences using a 530 combination of multiple tools for more robust enrichment determination 94 . Functional enrichment 531 for these enhancers was determined as above using GREAT 58 . 532
Identification of Enhancer Clusters
533
To identify clusters of craniofacial enhancers we first generated overlapping 200kb windows 534 with a 50kb step size 84 . Next, we intersected these windows with all enhancer chromatin state 535 segmentations from craniofacial tissues. We then calculated the fraction of each window 536 annotated as an enhancer state. We tested for enrichment of enhancers in each window using 537 permutation testing by randomly shuffling the craniofacial enhancer segments across the 538 genome 1000 times using BEDtools 84 and determining the fraction of each window annotated as 539 an enhancer. Overlapping windows of significant enrichment were merged into a single 540 contiguous region. Final enriched regions were assessed for overlap with gene annotations and 541 validated craniofacial enhancers using BEDtools 84 . 542 Transgenic Enhancer Assay 543 A 2.6 kb segment centered on the conserved sequence corresponding to HACNS50 71 was 544 amplified from human genomic DNA by polymerase chain reaction (PCR) using the following 545 primers: HACNS50 F 5'-CACCCCATTTCTGAGGGGGAAATAA-3', HACNS50 R 5'-546 TTATTTCCTTCAGGCCCTTG-3', and cloned into an Hsp68-lacZ reporter vector as previously 547 described 95 . Generation of transgenic mice at the Yale University Transgenic Mouse Facility and 548 embryo staining were carried out as previously described 95 . We required reporter gene 549 expression in a given structure to be present in at least three independent transgenic embryos 550 as assessed by two researchers to be considered reproducible. selected using a primer database generated for NlaIII/DpnII digestion as previously described 76 . 561
The sequences added to these primers were modified to allow hybridization to NextSeq 500 562 flow cells and split across two sets of primers to improve efficiency and allow for dense 563 multiplexing (Table S9) . 564
4C-seq Data Analysis
565
4C-seq libraries were sequenced for 75 cycles using the NextSeq500 (Illumina). Fastq files 566 were demultiplexed by barcode yielding Fastq files for each tissue replicate. Tissue replicate 567
Fastq files were further demultiplexed by viewpoint using Cutadapt (v1.8.3) 96 . Trimmed reads 568 were uniquely aligned to mm9 using bowtie2 82 . Significant interactions in craniofacial tissue 569 were assessed using r3Cseq 97 with a modification allowing a larger viewing window near the 570 viewpoint (https://github.com/cotneylab/r3Cseq) and using brain as a control. The significant 571 interactions are represented in the accompanying track hub as bigBed files. The location of the 572 viewpoint and sequenced interacting fragment are denoted with thick bars. A thin bar is included 573 to denote the connection between the viewpoint and the distal sites. 574 containing only imputed data. These imputed datasets were then used to predict chromatin 812 states using a Hidden Markov Model approach (ChromHMM) 44 across the genome for each 813 craniofacial tissue sample. These chromatin states were then used for downstream functional 814 analyses to determine relevance for craniofacial biology and disease. 
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